R Squared’s NRC Health Common Stock NRC Stock Holding History

R Squared’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-990	Closed	-$17.5K	–	1076
2024 Q4	$17.5K	Buy	+990	New	+$18.8K	0.02%	946

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

R Squared's NRC Position: Q1 2025 in Review

R Squared sold out of NRC Health Common Stock (NRC) in Q1 2025, closing a stake of 990 shares — an estimated $17.5K sold.

R Squared first reported a position in NRC in Q4 2024 and held it in 1 quarter. The position peaked at $17.5K in Q4 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q1 2025.

R Squared reported no remaining NRC Health Common Stock position as of Q1 2025 after selling out during the quarter.
R Squared sold 990 NRC Health Common Stock shares in Q1 2025, an estimated $17.5K.
R Squared first reported a position in NRC Health Common Stock in Q4 2024 and held it in 1 quarter.
R Squared's NRC Health Common Stock position peaked at $17.5K in Q4 2024.
123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.